Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document C2007/269/116

Case T-355/07: Action brought on 18 September 2007 — Pfizer v OHIM — Isdin (ISDIN Pediatrícs)

OJ C 269, 10.11.2007, p. 64–64 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

10.11.2007   

EN

Official Journal of the European Union

C 269/64


Action brought on 18 September 2007 — Pfizer v OHIM — Isdin (ISDIN Pediatrícs)

(Case T-355/07)

(2007/C 269/116)

Language in which the application was lodged: English

Parties

Applicant: Pfizer Ltd (Sandwich, United Kingdom) (represented by: V. von Bomhard, A. Renck, T. Dolde, lawyers, and M. Hawkins, Solicitor)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Other party to the proceedings before the Board of Appeal: Isdin, SA (Barcelona, Spain)

Form of order sought

Annul the Decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 28 June 2007 in Case R 566/2006-1; and

order that the costs of the proceedings be borne by the defendant.

Pleas in law and main arguments

Registered Community trade mark subject of the application for a declaration of invalidity: The figurative mark ‘ISDIN Pediatrícs’ for products in among others class 5 — Community trade mark No 1 243 807

Proprietor of the Community trade mark: Isdin, SA

Party requesting the declaration of invalidity of the Community trade mark: The applicant

Trade mark right of the party requesting the declaration of invalidity: The national word mark ‘ISTIN’ for goods in class 5

Decision of the Cancellation Division: Partial declaration of invalidity of the Community trade mark

Decision of the Board of Appeal: Annulment of the Cancellation Division's decision insofar as it declared the invalidity of the Community trade mark

Pleas in law: Violation of the applicant's right to be heard pursuant to Article 73 of Council Regulation No 40/94 and violation of Article 52 read in conjunction with Article 8(1)(b) of the regulation.


Top